Systematic investigation of non-nucleoside inhibitors of HIV-1 reverse transcriptase (NNRTIs)

被引：6
|
作者：
Beyer, A
Lawtrakul, L
Hannongbua, S
Wolschann, P
机构：
[1] Res Inst Mol Pathol, A-1030 Vienna, Austria
[2] Thammasat Univ, SIIT, Dept Common & Grad Studies, Pathum Thani 12121, Thailand
[3] Kasetsart Univ, Fac Sci, Dept Chem, Bangkok 10900, Thailand
[4] Inst Theoret Chem & Struct Biol, A-1090 Vienna, Austria
来源：
MONATSHEFTE FUR CHEMIE | 2004年 / 135卷 / 08期
关键词：
non-nucleoside reverse transcriptase inhibitors (NNRTIs); inhibition mechanism; viral mutation; drug resistance;
D O I：
10.1007/s00706-004-0173-y
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
The 44 crystal structures of NNRTIs complexed with HIV-1 reverse transcriptase (RT) have been analyzed in detail especially the orientation geometries and the distances between inhibitor molecules and surrounding amino acids. In general, various NNIs bind to the same region of the HIV-1 RT in the palm subdomain of p66, but subtle differences in individual interactions between RT and its inhibitors can be detected by comparison of all structures in this study.
引用
收藏
页码：1047 / 1059
页数：13
相关论文
共 50 条
  • [31] Selected non-nucleoside reverse transcriptase inhibitors (NNRTIs): the DABOs family
    Artico, M
    DRUGS OF THE FUTURE, 2002, 27 (02) : 159 - 175
  • [32] In silico screening of HIV-1 non-nucleoside reverse transcriptase and protease inhibitors
    Leitao, Andrei
    Andricopulo, Adriano D.
    Montanari, Carlos A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (07) : 1412 - 1422
  • [33] Non-nucleoside inhibitors of HIV-1 reverse transcriptase binding calculations.
    Zhou, ZG
    Madrid, M
    Madura, JD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U397 - U397
  • [34] PYRIDONE DIARYL ETHER NON-NUCLEOSIDE INHIBITORS OF HIV-1 REVERSE TRANSCRIPTASE
    Kennedy-Smith, Joshua
    Arora, Nidhi
    Billedeau, Roland
    Fretland, Jennifer
    Hang, Julie
    Heilek, Gabrielle
    Harris, Seth
    Hirschfeld, Donald
    Javanbakht, Hassan
    Li, Yu
    Liang, Weiling
    Roetz, Ralf
    Smith, Mark
    Su, Guoping
    Suh, Judy
    Sweeney, Zachary
    Villasenor, Armando
    Wu, Jeffrey
    Yasuda, Dennis
    Klumpp, Klaus
    DRUGS OF THE FUTURE, 2009, 34 : 150 - 150
  • [35] Next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors
    Boone, LR
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (02) : 128 - 135
  • [36] Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Sweeney, Zachary K.
    Dunn, James P.
    Li, Yu
    Heilek, Gabrielle
    Dunten, Pete
    Elworthy, Todd R.
    Han, Xiaochun
    Harris, Seth F.
    Hirschfeld, Donald R.
    Hogg, J. Heather
    Huber, Walter
    Kaiser, Ann C.
    Kertesz, Denis J.
    Kim, Woongki
    Mirzadegan, Taraneh
    Roepel, Michael G.
    Saito, Y. David
    Silva, Tania M. P. C.
    Swallow, Steven
    Tracy, Jahari L.
    Villasenor, Armando
    Vora, Harit
    Zhou, Amy S.
    Klumpp, Klaus
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (15) : 4352 - 4354
  • [37] The role of non-nucleoside reverse transcriptase inhibitors in children with HIV-1 infection
    Maddocks S.
    Dwyer D.
    Paediatric Drugs, 2001, 3 (9): : 681 - 702
  • [38] Unbinding Dynamics of Non-Nucleoside Inhibitors from HIV-1 Reverse Transcriptase
    Dodda, Leela S.
    Tirado-Rives, Julian
    Jorgensen, William L.
    JOURNAL OF PHYSICAL CHEMISTRY B, 2019, 123 (08): : 1741 - 1748
  • [39] Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors: A Combinatorial Approach
    Valuev-Elliston, V. T.
    Kochetkov, S. N.
    BIOCHEMISTRY-MOSCOW, 2017, 82 (13) : 1716 - 1743
  • [40] Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: A combinatorial approach
    V. T. Valuev-Elliston
    S. N. Kochetkov
    Biochemistry (Moscow), 2017, 82 : 1716 - 1743
12345